Clinical trials recruiting in Goyang, South Korea

Phase breakdown

Conditions recruiting in Goyang, South Korea

Recruiting trials in Goyang, South Korea

• An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
  NCT07033026 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
  NCT07195695 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
  NCT07405931 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female)
• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
  NCT06757634 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)
  NCT05534087 · Phase: Phase 3 · Ages: 19 Years to 75 Years · Sex: All (male and female)
• Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
  NCT06603558 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Goyang, South Korea?

6 recruiting trials have at least one study site in Goyang, South Korea.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.